Cargando…

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience

Detalles Bibliográficos
Autores principales:	Vidoevska, A., Jakovska, T., Momchilovik, S., Arnaudova-Danevska, I., Ginovska-Tasevska, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2022
Materias:	Poster Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184785/ http://dx.doi.org/10.1016/S1569-1993(22)00405-2

Ejemplares similares

Sputum Quality Assessment Regarding Sputum Culture for Diagnosing Lower Respiratory Tract Infections in Children
por: Popova, Gorica, et al.
Publicado: (2019)

P076 COVID-19 vaccination in children and adolescents with cystic fibrosis - a single-centre experience
por: Zver, A., et al.
Publicado: (2022)

ePS4.01 The impact of the SARS-CoV-2 pandemic on people with cystic fibrosis (CF) in Ireland: did individuals maintain their key health outcomes?
por: Rees, H., et al.
Publicado: (2022)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

P188 Vitamin D status at Bristol Adult CF Centre (BACFC) during the COVID-19 pandemic and following the introduction of the multivitamin Paravit CF
por: Keele, A., et al.
Publicado: (2022)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

ePS4.05 Evolving cystic fibrosis care during COVID-19: a single-centre experience
por: Spoletini, G., et al.
Publicado: (2022)

ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series
por: Gautschi, F., et al.
Publicado: (2022)

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

P175 Extended incubation of cystic fibrosis cultures: is it worth it?
por: Amado, R., et al.
Publicado: (2019)

P074 Post-COVID-19 condition in children with cystic fibrosis
por: Chernyavskaya, A., et al.
Publicado: (2022)

P075 COVID-19 vaccination uptake in patients with cystic fibrosis
por: Manning, D.-E., et al.
Publicado: (2022)

P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic
por: McCabe, D.
Publicado: (2022)

EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK
por: Connolly, A., et al.
Publicado: (2021)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Markelić, I., et al.
Publicado: (2022)

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

EPS1.06 A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre
por: Waller, I., et al.
Publicado: (2021)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

76: Sustaining routine cystic fibrosis care in a large pediatric CF program during COVID-19
por: Gordon, R., et al.
Publicado: (2021)

72: Development of a decision aid for adult-diagnosed cystic fibrosis in a community hospital CF program
por: Belkin, R., et al.
Publicado: (2021)

P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021)

P256 Change in the anxiety levels of children with cystic fibrosis and their mothers at the beginning of the COVID-19 pandemic and after 1 year
por: Asfuroglu, P., et al.
Publicado: (2022)

P086 The impact of COVID-19 in people with cystic fibrosis – a single-centre experience
por: Aldous, G., et al.
Publicado: (2021)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

P410 The impact of the COVID 19 pandemic and modulator therapy on routine respiratory sampling in paediatric cystic fibrosis (CF)
por: Millman, B., et al.
Publicado: (2023)

P073 Observed impact on admissions during the COVID-19 pandemic of paediatric cystic fibrosis patients in a tertiary hospital setting
por: Warraich, S., et al.
Publicado: (2022)

WS20.06 Co-infection with Nocardia farcinia and SARS-CoV-2 causing the death of an adolescent with cystic fibrosis
por: Chapman, J., et al.
Publicado: (2022)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF
por: Nakano, S., et al.
Publicado: (2021)

No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy
por: Scagnolari, Carolina, et al.
Publicado: (2020)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis
por: Mir, M.H., et al.
Publicado: (2022)

159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis
por: Kremer, T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u8retbu7m8j74uuugr6mbriaq0